Departments of Psychiatry, Erasmus Medical Centre, Rotterdam, The Netherlands.
J ECT. 2010 Mar;26(1):53-4. doi: 10.1097/YCT.0b013e3181b00f5b.
Postanesthesia bradycardia or asystole before electroconvulsive therapy (ECT) occurs very infrequently but is a potentially fatal complication of pre-ECT anesthesia. The optimal strategy for the prevention of its recurrence is unclear because the use of premedication with atropine may not always be successful. In this article, we present the case of a 21-year-old man with schizophrenia who developed bradycardia directly after receiving succinylcholine during the first 3 ECT sessions. Replacing succinylcholine with mivacurium seemed to be a successful strategy in preventing bradycardia during the final 9 ECT sessions.
在电抽搐治疗 (ECT) 前出现麻醉后心动过缓或心搏停止极为罕见,但却是 ECT 麻醉前潜在的致命并发症。预防其复发的最佳策略尚不清楚,因为使用阿托品进行预给药并不总是有效。本文报道了一例 21 岁男性精神分裂症患者,在第 3 次 ECT 治疗时直接在给予琥珀胆碱后发生心动过缓。在最后 9 次 ECT 治疗时,用米库氯铵替代琥珀胆碱似乎是预防心动过缓的有效策略。